A
ACAD
Acadia Pharmaceuticals Inc
21.19
-0.07-0.33%After Hours: 21.19 0.00 0.00%16:57 05/27 EDT
OPEN/PREV CLOSE21.48/21.26
TODAY RANGE21.14-21.60
VOL982.35K
MARKET CAP3.63B
52 WEEK RANGE19.69-28.35
AVG VOL (3M)1.83M
% TURNOVER0.57%
TURNOVER--
P/E (TTM)9.68
% RANGE2.05%
EPS(TTM)2.188
P/E(FORWARD)57.27
P/B2.905
BVPS7.30
DIVIDEND--
P/S3.368
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.59B
SHARES OUTSTANDING171.24M
NEXT EARNINGS08/04-08/10
FREE FLOAT169.21M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·6d ago
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Pipeline Progress And Product Rollouts
Simply Wall St·05/17 04:37
How ACADIA’s (ACAD) Solid Q1 Revenue and Pipeline Update Has Changed Its Investment Story
Seeking Alpha·05/14 18:40
Biopharmas look to China, elsewhere for partnerships, R&D
TipRanks·05/11 12:05
BMO Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)
Simply Wall St·05/10 22:21
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Mixed Q1 2026 Results And EU Trofinetide Setback
Simply Wall St·05/08 22:00
Acadia Pharmaceuticals (ACAD) Margin Expansion To 34.3% Tests Bearish Growth Concerns
Dow Jones·05/08 20:52
ACADIA Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones·05/08 20:52
ACADIA Pharmaceuticals Price Target Cut to $32.00/Share From $33.00 by Citigroup
Benzinga·05/08 20:43
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $32
TipRanks·05/08 11:44
Guggenheim Keeps Their Hold Rating on ACADIA Pharmaceuticals (ACAD)
TipRanks·05/08 11:24
Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi
TipRanks·05/08 02:07
ACADIA Pharmaceuticals Signals Confident Path After Q1 Call